Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Caspase-3 and beclin-1 in patients with and without intra-aortic balloon pump after cardiac arrest: Study of apoptosis and autophagy

Heart Science Journal · Vol. 7 No. 3 (2026) · hlm. 69–73

DOI
10.21776/ub.hsj.2026.007.03.11
ISSN
2721-9984, 2721-9976
Terbit
2026-07-14
Penerbit
Universitas Brawijaya
Bahasa
en
Lisensi
creativecommons.org/licenses/by/4.0

Abstrak

Background: Ischemic and reperfusion injuries occur during cardiac arrest and after successful resuscitation, potentially triggering apoptosis and autophagy, which can cause irreversible cell damage or death. Beclin-1 and Caspase-3 are proteins that play roles in autophagy and apoptosis pathways. However, it remains unclear whether the insertion of an IABP influences the serum levels of these proteins in patients with cardiac arrest and acute coronary syndrome (ACS). Objective: To investigate the Caspace-3 and Beclin-1 serum levels after Intra-Aortic Balloon Pumps (IABP) in cardiac arrest survivors with ACS. Methods: This is a single-center prospective randomized control trial (RCT) study using an unpaired t-test and a Mann-Whitney U-test to analyze the data (p-value<0.05). Result: This study included sixty subjects: 48 males and 12 females, with a mean age of 60.3 ± 9.85 years. The result showed there’s no significant difference in Beclin-1 and Caspase-3 serum levels before and after the insertion of IABP in both survival and non-survival groups (p=0.676). Caspace-3 serum level was higher in non-survival group. ROC curve analysis showed the caspase-3 level has a predictive value for mortality in cardiac arrest survivors with ACS (p=0.012). Conclusion: IABP insertion in cardiac arrest patients with ACS doesn’t significantly affect Beclin-1 and Caspase-3 levels. Caspase-3 serum levels may predict mortality in these patients, with a sensitivity of 64% and a specificity of 66.7%.

Kata kunci

Jaringan kolaborasi para penulis

21 penulis · 65 tautan kepenulisan bersama · 18 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • IPB University
  • Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
  • Taipei Veterans General Hospital
  • Kementerian Kesehatan Republik Indonesia
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Irma Herawati SupartoIPB University1
Arief BoedionoIPB University1
Dondin SajuthiIPB University1
Agus HarsoyoIPB University1
Sunu Budhi RaharjoUniversity of Indonesia1
Dony Yugo HermantoUniversity of Indonesia1
Indira Aura BalqisUniversity of Indonesia1
Dicky Armein HanafyUniversity of Indonesia1
Ira PosangiUniversity of Indonesia1
Ridwan R. WaliyuddinUniversity of Indonesia1
Chin‐Yu LinTaipei Veterans General Hospital1
Rika BurRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1
Suhendro SuwartoKementerian Kesehatan Republik Indonesia1
Widayat Djoko SantosoRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://heartscience.ub.ac.id/index.php/heartscience/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Caspase-3 and beclin-1 in patients with and without intra-aortic balloon pump after cardiac arrest: Study of apoptosis and autophagy</dc:title>
	<dc:creator xml:lang="en">Firdaus, Isman</dc:creator>
	<dc:creator xml:lang="en">Bunga Dewanggi</dc:creator>
	<dc:creator xml:lang="en">Kartika, Gloria</dc:creator>
	<dc:creator xml:lang="en">Andriantoro, Hananto</dc:creator>
	<dc:creator xml:lang="en">Yuniadi, Yoga</dc:creator>
	<dc:creator xml:lang="en">Boom, Cindy Elfira</dc:creator>
	<dc:creator xml:lang="en">Harimurti, Kuntjoro</dc:creator>
	<dc:subject xml:lang="en">Beclin-1</dc:subject>
	<dc:subject xml:lang="en">Cardiac Arrest Survivor</dc:subject>
	<dc:subject xml:lang="en">Caspase-3</dc:subject>
	<dc:subject xml:lang="en">Critical Care</dc:subject>
	<dc:subject xml:lang="en">IABP</dc:subject>
	<dc:description xml:lang="en">Background: Ischemic and reperfusion injuries occur during cardiac arrest and after successful resuscitation, potentially triggering apoptosis and autophagy, which can cause irreversible cell damage or death. Beclin-1 and Caspase-3 are proteins that play roles in autophagy and apoptosis pathways. However, it remains unclear whether the insertion of an IABP influences the serum levels of these proteins in patients with cardiac arrest and acute coronary syndrome (ACS).
Objective: To investigate the Caspace-3 and Beclin-1 serum levels after Intra-Aortic Balloon Pumps (IABP) in cardiac arrest survivors with ACS.
Methods: This is a single-center prospective randomized control trial (RCT) study using an unpaired t-test and a Mann-Whitney U-test to analyze the data (p-value&amp;lt;0.05).
Result: This study included sixty subjects: 48 males and 12 females, with a mean age of 60.3 ± 9.85 years. The result showed there’s no significant difference in Beclin-1 and Caspase-3 serum levels before and after the insertion of IABP in both survival and non-survival groups (p=0.676). Caspace-3 serum level was higher in non-survival group. ROC curve analysis showed the caspase-3 level has a predictive value for mortality in cardiac arrest survivors with ACS (p=0.012).
Conclusion: IABP insertion in cardiac arrest patients with ACS doesn’t significantly affect Beclin-1 and Caspase-3 levels. Caspase-3 serum levels may predict mortality in these patients, with a sensitivity of 64% and a specificity of 66.7%.</dc:description>
	<dc:publisher xml:lang="en">Universitas Brawijaya</dc:publisher>
	<dc:date>2026-07-14</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://heartscience.ub.ac.id/index.php/heartscience/article/view/20679</dc:identifier>
	<dc:identifier>10.21776/ub.hsj.2026.007.03.11</dc:identifier>
	<dc:source xml:lang="en">Heart Science Journal; Vol. 7 No. 3 (2026): Predicting Restenosis in Coronary Artery Disease; 69-73</dc:source>
	<dc:source>2721-9984</dc:source>
	<dc:source>2721-9976</dc:source>
	<dc:source>10.21776/ub.hsj.2026.007.03</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://heartscience.ub.ac.id/index.php/heartscience/article/view/20679/603</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2026 Isman Firdaus, Bunga Dewanggi</dc:rights>
	<dc:rights xml:lang="en">http://creativecommons.org/licenses/by/4.0</dc:rights>
</oai_dc:dc>